The present invention provides strategies for inhibiting the action of microglial neurotoxins, thus making possible the treatment of and screening for therapies for inflammatory injury to neurons in neurodegenerative diseases and disorders such as Alzheimer's Disease, stroke, trauma, multiple sclerosis (MS), Parkinson's disease, HIV infection of the central nervous system, AIDS dementia, amyotroph